25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Sansure Biotech Inc
Buy, Hold or Sell?

Let's analyze Sansure together

I guess you are interested in Sansure Biotech Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sansure Biotech Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Sansure Biotech Inc

I send you an email if I find something interesting about Sansure Biotech Inc.

1. Quick Overview

1.1. Quick analysis of Sansure (30 sec.)










1.2. What can you expect buying and holding a share of Sansure? (30 sec.)

How much money do you get?

How much money do you get?
¥0.10
When do you have the money?
1 year
How often do you get paid?
63.6%

What is your share worth?

Current worth
¥12.60
Expected worth in 1 year
¥12.58
How sure are you?
81.8%

+ What do you gain per year?

Total Gains per Share
¥0.68
Return On Investment
3.2%

For what price can you sell your share?

Current Price per Share
¥21.33
Expected price per share
¥18.46 - ¥25.50
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Sansure (5 min.)




Live pricePrice per Share (EOD)
¥21.33
Intrinsic Value Per Share
¥-80.66 - ¥-96.90
Total Value Per Share
¥-68.06 - ¥-84.29

2.2. Growth of Sansure (5 min.)




Is Sansure growing?

Current yearPrevious yearGrowGrow %
How rich?$1b$1b$255.2k0.0%

How much money is Sansure making?

Current yearPrevious yearGrowGrow %
Making money$8.9m$21.9m-$12.9m-146.0%
Net Profit Margin18.3%40.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Sansure (5 min.)




2.4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Sansure?

Welcome investor! Sansure's management wants to use your money to grow the business. In return you get a share of Sansure.

First you should know what it really means to hold a share of Sansure. And how you can make/lose money.

Speculation

The Price per Share of Sansure is ¥21.33. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sansure.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sansure, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥12.60. Based on the TTM, the Book Value Change Per Share is ¥-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.18 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sansure.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.0%0.020.1%0.040.2%0.090.4%0.070.3%
Usd Book Value Change Per Share-0.01-0.1%0.000.0%-0.02-0.1%0.090.4%0.080.4%
Usd Dividend Per Share0.030.2%0.020.1%0.040.2%0.020.1%0.020.1%
Usd Total Gains Per Share0.020.1%0.020.1%0.020.1%0.110.5%0.090.4%
Usd Price Per Share2.95-2.67-2.72-5.27-4.56-
Price to Earnings Ratio80.98-48.78-39.43-25.82-22.30-
Price-to-Total Gains Ratio128.42-131.46-57.72-84.96-84.96-
Price to Book Ratio1.71-1.54-1.56-3.90-3.37-
Price-to-Total Gains Ratio128.42-131.46-57.72-84.96-84.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.928609
Number of shares341
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.000.09
Usd Total Gains Per Share0.020.11
Gains per Quarter (341 shares)7.9737.26
Gains per Year (341 shares)31.86149.05
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
133-12225124139
266-25450248288
398-38674373437
4131-411899497586
5164-5150124621735
6197-6182149745884
7230-72141748701033
8263-82461999941182
9295-927822311181331
10328-1031024812421480

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.00.00.0100.0%19.00.00.0100.0%21.01.00.095.5%21.01.00.095.5%
Book Value Change Per Share1.03.00.025.0%6.05.00.054.5%14.05.00.073.7%14.05.03.063.6%14.05.03.063.6%
Dividend per Share4.00.00.0100.0%11.00.00.0100.0%14.00.05.073.7%14.00.08.063.6%14.00.08.063.6%
Total Gains per Share4.00.00.0100.0%10.01.00.090.9%18.01.00.094.7%18.01.03.081.8%18.01.03.081.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Sansure Biotech Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.080-0.005-94%-0.180+125%0.663-112%0.573-114%
Book Value Per Share--12.60412.675-1%12.6450%10.022+26%8.655+46%
Current Ratio--8.0407.947+1%6.504+24%7.124+13%6.152+31%
Debt To Asset Ratio--0.1420.135+6%0.135+5%0.142+0%0.122+16%
Debt To Equity Ratio--0.1680.159+6%0.157+7%0.170-1%0.147+14%
Dividend Per Share--0.2480.175+41%0.320-23%0.133+87%0.114+116%
Enterprise Value--11324714982.57010279478061.825+10%11892689551.523-5%28212299301.529-60%28212299301.529-60%
Eps--0.0660.110-40%0.271-76%0.624-89%0.541-88%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--8.9707.371+22%9.666-7%9.047-1%9.047-1%
Free Cash Flow Per Share---0.015-0.064+338%-0.303+1984%0.250-106%0.211-107%
Free Cash Flow To Equity Per Share---0.015-0.064+338%-0.552+3695%0.294-105%0.253-106%
Gross Profit Margin--1.0001.0000%0.703+42%0.740+35%2.949-66%
Intrinsic Value_10Y_max---96.895--------
Intrinsic Value_10Y_min---80.664--------
Intrinsic Value_1Y_max---1.988--------
Intrinsic Value_1Y_min---1.948--------
Intrinsic Value_3Y_max---11.858--------
Intrinsic Value_3Y_min---11.202--------
Intrinsic Value_5Y_max---28.823--------
Intrinsic Value_5Y_min---26.246--------
Market Cap12358346722.560-1%12542842129.00011437407203.073+10%11648561800.385+8%22339714212.692-44%19293389547.325-35%
Net Profit Margin--0.1230.183-33%0.400-69%0.392-69%0.349-65%
Operating Margin----0%0.047-100%0.151-100%0.137-100%
Operating Ratio--1.1881.091+9%1.142+4%0.736+61%0.759+56%
Pb Ratio1.692-1%1.7061.537+11%1.562+9%3.898-56%3.367-49%
Pe Ratio80.341-1%80.98248.785+66%39.430+105%25.825+214%22.303+263%
Price Per Share21.330-1%21.50019.483+10%19.795+9%38.416-44%33.178-35%
Price To Free Cash Flow Ratio-366.442+1%-369.363-105.556-71%-20.342-94%-30.479-92%-26.323-93%
Price To Total Gains Ratio127.402-1%128.417131.465-2%57.716+122%84.962+51%84.962+51%
Quick Ratio--1.0631.444-26%4.009-73%5.670-81%4.897-78%
Return On Assets--0.0050.008-40%0.018-75%0.077-94%0.067-93%
Return On Equity--0.0050.009-40%0.021-75%0.096-94%0.083-94%
Total Gains Per Share--0.1670.170-2%0.140+20%0.796-79%0.687-76%
Usd Book Value--1009576134.6111021899893.702-1%1021644655.332-1%803851573.158+26%694235449.546+45%
Usd Book Value Change Per Share---0.011-0.001-94%-0.025+125%0.091-112%0.079-114%
Usd Book Value Per Share--1.7311.740-1%1.7360%1.376+26%1.188+46%
Usd Dividend Per Share--0.0340.024+41%0.044-23%0.018+87%0.016+116%
Usd Enterprise Value--1554883367.1071411372337.889+10%1632866275.424-5%3873548694.100-60%3873548694.100-60%
Usd Eps--0.0090.015-40%0.037-76%0.086-89%0.074-88%
Usd Free Cash Flow---1165611.025-5147635.750+342%-24500463.266+2002%19770653.402-106%16682937.955-107%
Usd Free Cash Flow Per Share---0.002-0.009+338%-0.042+1984%0.034-106%0.029-107%
Usd Free Cash Flow To Equity Per Share---0.002-0.009+338%-0.076+3695%0.040-105%0.035-106%
Usd Market Cap1696801005.007-1%1722132224.3121570356008.982+10%1599347535.193+8%3067242761.403-44%2648982384.848-35%
Usd Price Per Share2.929-1%2.9522.675+10%2.718+9%5.275-44%4.555-35%
Usd Profit--5316421.0618904748.678-40%21904711.694-76%49793133.739-89%43119448.119-88%
Usd Revenue--43335049.63848300635.929-10%103478439.267-58%120262129.672-64%105381522.709-59%
Usd Total Gains Per Share--0.0230.023-2%0.019+20%0.109-79%0.094-76%
 EOD+3 -5MRQTTM+15 -22YOY+16 -235Y+12 -2710Y+10 -29

3.3 Fundamental Score

Let's check the fundamental score of Sansure Biotech Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1580.341
Price to Book Ratio (EOD)Between0-11.692
Net Profit Margin (MRQ)Greater than00.123
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.063
Current Ratio (MRQ)Greater than18.040
Debt to Asset Ratio (MRQ)Less than10.142
Debt to Equity Ratio (MRQ)Less than10.168
Return on Equity (MRQ)Greater than0.150.005
Return on Assets (MRQ)Greater than0.050.005
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Sansure Biotech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.651
Ma 20Greater thanMa 5021.874
Ma 50Greater thanMa 10021.601
Ma 100Greater thanMa 20022.071
OpenGreater thanClose21.350
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Sansure Biotech Inc

Sansure Biotech Inc. engages in the research and development, production, and sale of in vitro diagnostic reagents and instruments in China. It offers nucleic acid and multiple nucleic acid diagnostic kits for coronavirus, CoV-2, influenza virus, and respiratory syncytial virus; DNA fluorescence and nucleic acid diagnostic kits for respiratory tract infections, HPV infections, and reproductive tract infections; nucleic acid tests and fluorescence diagnostic kits for blood-borne infections; RNA diagnostic kits for gastrointestinal infections; and diagnostic kits for monkeypox, epstein-barr virus, and human cytomegalovirus DNA, as well as rapid antigen tests. The company provides nucleic acid extraction or purification kits, multi-type sample DNA/RNA extraction-purification kits, and sample release reagents; sample storage reagents for SARS-CoV-2; extraction instruments and systems; and PCR instruments comprising real-time quantitative thermal cyclers, portable molecule workstations, and real-time PCR systems. In addition, it engages in the research and development, production, and sale of drugs; procurement and sale of raw materials; manufacture of instruments; manufacture and sale of electronic equipment; trading; investment advisory; medical research and experimental development; and internet sales, as well as offers third-party medical testing and biotechnology development services. The company was founded in 2008 and is headquartered in Changsha, China.

Fundamental data was last updated by Penke on 2025-02-15 00:59:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Sansure earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Sansure to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 12.3% means that ¥0.12 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sansure Biotech Inc:

  • The MRQ is 12.3%. The company is making a huge profit. +2
  • The TTM is 18.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ12.3%TTM18.3%-6.1%
TTM18.3%YOY40.0%-21.7%
TTM18.3%5Y39.2%-20.8%
5Y39.2%10Y34.9%+4.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ12.3%4.9%+7.4%
TTM18.3%4.6%+13.7%
YOY40.0%6.5%+33.5%
5Y39.2%6.9%+32.3%
10Y34.9%7.3%+27.6%
4.3.1.2. Return on Assets

Shows how efficient Sansure is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sansure to the Medical Instruments & Supplies industry mean.
  • 0.5% Return on Assets means that Sansure generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sansure Biotech Inc:

  • The MRQ is 0.5%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.8%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.5%TTM0.8%-0.3%
TTM0.8%YOY1.8%-1.1%
TTM0.8%5Y7.7%-7.0%
5Y7.7%10Y6.7%+1.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5%0.9%-0.4%
TTM0.8%0.8%0.0%
YOY1.8%1.5%+0.3%
5Y7.7%1.9%+5.8%
10Y6.7%1.7%+5.0%
4.3.1.3. Return on Equity

Shows how efficient Sansure is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sansure to the Medical Instruments & Supplies industry mean.
  • 0.5% Return on Equity means Sansure generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sansure Biotech Inc:

  • The MRQ is 0.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.5%TTM0.9%-0.4%
TTM0.9%YOY2.1%-1.2%
TTM0.9%5Y9.6%-8.7%
5Y9.6%10Y8.3%+1.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5%2.0%-1.5%
TTM0.9%1.6%-0.7%
YOY2.1%2.7%-0.6%
5Y9.6%3.3%+6.3%
10Y8.3%3.3%+5.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Sansure Biotech Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Sansure is operating .

  • Measures how much profit Sansure makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sansure to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sansure Biotech Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY4.7%-4.7%
TTM-5Y15.1%-15.1%
5Y15.1%10Y13.7%+1.4%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.5%-7.5%
TTM-6.9%-6.9%
YOY4.7%8.8%-4.1%
5Y15.1%9.4%+5.7%
10Y13.7%9.3%+4.4%
4.3.2.2. Operating Ratio

Measures how efficient Sansure is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.19 means that the operating costs are ¥1.19 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Sansure Biotech Inc:

  • The MRQ is 1.188. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.091. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.188TTM1.091+0.098
TTM1.091YOY1.142-0.051
TTM1.0915Y0.736+0.355
5Y0.73610Y0.759-0.023
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1881.089+0.099
TTM1.0911.094-0.003
YOY1.1421.001+0.141
5Y0.7361.018-0.282
10Y0.7590.991-0.232
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Sansure Biotech Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Sansure is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 8.04 means the company has ¥8.04 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Sansure Biotech Inc:

  • The MRQ is 8.040. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.947. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.040TTM7.947+0.093
TTM7.947YOY6.504+1.443
TTM7.9475Y7.124+0.823
5Y7.12410Y6.152+0.971
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ8.0402.030+6.010
TTM7.9472.069+5.878
YOY6.5042.471+4.033
5Y7.1242.654+4.470
10Y6.1522.606+3.546
4.4.3.2. Quick Ratio

Measures if Sansure is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sansure to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 1.06 means the company can pay off ¥1.06 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sansure Biotech Inc:

  • The MRQ is 1.063. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.444. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.063TTM1.444-0.381
TTM1.444YOY4.009-2.565
TTM1.4445Y5.670-4.226
5Y5.67010Y4.897+0.773
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0630.917+0.146
TTM1.4441.061+0.383
YOY4.0091.231+2.778
5Y5.6701.482+4.188
10Y4.8971.607+3.290
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Sansure Biotech Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Sansure assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sansure to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.14 means that Sansure assets are financed with 14.2% credit (debt) and the remaining percentage (100% - 14.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sansure Biotech Inc:

  • The MRQ is 0.142. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.135. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.142TTM0.135+0.008
TTM0.135YOY0.1350.000
TTM0.1355Y0.142-0.007
5Y0.14210Y0.122+0.019
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1420.385-0.243
TTM0.1350.362-0.227
YOY0.1350.346-0.211
5Y0.1420.365-0.223
10Y0.1220.376-0.254
4.5.4.2. Debt to Equity Ratio

Measures if Sansure is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sansure to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 16.8% means that company has ¥0.17 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sansure Biotech Inc:

  • The MRQ is 0.168. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.159. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.168TTM0.159+0.009
TTM0.159YOY0.157+0.002
TTM0.1595Y0.170-0.011
5Y0.17010Y0.147+0.023
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1680.576-0.408
TTM0.1590.538-0.379
YOY0.1570.520-0.363
5Y0.1700.597-0.427
10Y0.1470.664-0.517
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Sansure generates.

  • Above 15 is considered overpriced but always compare Sansure to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 80.98 means the investor is paying ¥80.98 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sansure Biotech Inc:

  • The EOD is 80.341. Based on the earnings, the company is expensive. -2
  • The MRQ is 80.982. Based on the earnings, the company is expensive. -2
  • The TTM is 48.785. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD80.341MRQ80.982-0.640
MRQ80.982TTM48.785+32.197
TTM48.785YOY39.430+9.355
TTM48.7855Y25.825+22.960
5Y25.82510Y22.303+3.522
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD80.34114.200+66.141
MRQ80.98215.824+65.158
TTM48.78516.455+32.330
YOY39.43020.051+19.379
5Y25.82520.884+4.941
10Y22.30325.800-3.497
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sansure Biotech Inc:

  • The EOD is -366.442. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -369.363. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -105.556. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-366.442MRQ-369.363+2.921
MRQ-369.363TTM-105.556-263.806
TTM-105.556YOY-20.342-85.214
TTM-105.5565Y-30.479-75.077
5Y-30.47910Y-26.323-4.156
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-366.44210.229-376.671
MRQ-369.3639.744-379.107
TTM-105.5568.090-113.646
YOY-20.342-0.086-20.256
5Y-30.4795.972-36.451
10Y-26.3232.509-28.832
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Sansure is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 1.71 means the investor is paying ¥1.71 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Sansure Biotech Inc:

  • The EOD is 1.692. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.706. Based on the equity, the company is underpriced. +1
  • The TTM is 1.537. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.692MRQ1.706-0.013
MRQ1.706TTM1.537+0.168
TTM1.537YOY1.562-0.025
TTM1.5375Y3.898-2.361
5Y3.89810Y3.367+0.532
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD1.6922.604-0.912
MRQ1.7062.632-0.926
TTM1.5372.733-1.196
YOY1.5622.786-1.224
5Y3.8983.856+0.042
10Y3.3674.374-1.007
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets8,571,194
Total Liabilities1,218,127
Total Stockholder Equity7,238,108
 As reported
Total Liabilities 1,218,127
Total Stockholder Equity+ 7,238,108
Total Assets = 8,571,194

Assets

Total Assets8,571,194
Total Current Assets5,742,695
Long-term Assets2,828,500
Total Current Assets
Cash And Cash Equivalents 4,418,064
Short-term Investments 150,736
Net Receivables 608,556
Inventory 419,030
Other Current Assets 21,972
Total Current Assets  (as reported)5,742,695
Total Current Assets  (calculated)5,618,358
+/- 124,336
Long-term Assets
Property Plant Equipment 1,070,437
Goodwill 7,662
Intangible Assets 428,533
Long-term Assets Other 28,818
Long-term Assets  (as reported)2,828,500
Long-term Assets  (calculated)1,535,450
+/- 1,293,049

Liabilities & Shareholders' Equity

Total Current Liabilities714,280
Long-term Liabilities503,847
Total Stockholder Equity7,238,108
Total Current Liabilities
Short Long Term Debt 9,000
Accounts payable 421,353
Other Current Liabilities 509
Total Current Liabilities  (as reported)714,280
Total Current Liabilities  (calculated)430,862
+/- 283,418
Long-term Liabilities
Long term Debt 400,761
Capital Lease Obligations Min Short Term Debt16,548
Long-term Liabilities  (as reported)503,847
Long-term Liabilities  (calculated)417,309
+/- 86,538
Total Stockholder Equity
Retained Earnings 4,883,690
Total Stockholder Equity (as reported)7,238,108
Total Stockholder Equity (calculated)4,883,690
+/- 2,354,417
Other
Capital Stock583,388
Common Stock Shares Outstanding 583,388
Net Invested Capital 7,647,869
Net Working Capital 5,028,415
Property Plant and Equipment Gross 1,070,437



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
0
0
0
642,465
1,029,255
2,499,772
5,157,991
5,454,374
6,231,126
6,359,174
7,069,508
7,811,155
8,144,475
8,597,333
9,173,762
8,727,055
8,242,561
8,307,764
8,454,205
8,745,537
8,632,080
8,571,194
8,571,1948,632,0808,745,5378,454,2058,307,7648,242,5618,727,0559,173,7628,597,3338,144,4757,811,1557,069,5086,359,1746,231,1265,454,3745,157,9912,499,7721,029,255642,465000
   > Total Current Assets 
0
0
0
437,204
821,235
2,266,239
4,861,573
5,082,704
5,696,702
5,194,501
6,145,094
6,583,928
6,777,012
7,096,986
7,525,436
7,049,797
6,263,942
6,086,683
5,949,594
6,110,526
5,903,884
5,742,695
5,742,6955,903,8846,110,5265,949,5946,086,6836,263,9427,049,7977,525,4367,096,9866,777,0126,583,9286,145,0945,194,5015,696,7025,082,7044,861,5732,266,239821,235437,204000
       Cash And Cash Equivalents 
0
0
0
99,166
170,408
496,545
822,338
2,590,800
2,506,195
3,333,754
2,351,467
3,076,523
2,203,151
2,457,151
3,212,589
2,451,468
2,487,240
3,462,325
4,233,488
4,330,821
4,315,047
4,418,064
4,418,0644,315,0474,330,8214,233,4883,462,3252,487,2402,451,4683,212,5892,457,1512,203,1513,076,5232,351,4673,333,7542,506,1952,590,800822,338496,545170,40899,166000
       Short-term Investments 
0
0
0
66,329
177,324
773,073
2,940,062
1,601,225
1,872,007
707,385
2,548,369
1,986,347
2,907,579
2,911,229
2,451,199
3,017,385
2,382,693
1,351,414
548,279
617,210
402,832
150,736
150,736402,832617,210548,2791,351,4142,382,6933,017,3852,451,1992,911,2292,907,5791,986,3472,548,369707,3851,872,0071,601,2252,940,062773,073177,32466,329000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
871,038
915,917
938,518
1,276,299
1,040,917
877,356
778,775
689,548
661,552
666,914
608,556
608,556666,914661,552689,548778,775877,3561,040,9171,276,299938,518915,917871,03800000000000
       Other Current Assets 
0
0
0
207,047
371,221
814,849
869,110
613,943
822,976
750,587
809,183
33,733
41,974
19,680
33,592
42,210
32,949
16,892
21,769
24,742
21,936
21,972
21,97221,93624,74221,76916,89232,94942,21033,59219,68041,97433,733809,183750,587822,976613,943869,110814,849371,221207,047000
   > Long-term Assets 
0
0
0
205,261
208,020
233,532
296,418
371,670
534,424
1,164,674
924,414
1,227,226
1,367,463
1,500,346
1,648,326
1,677,257
1,978,619
2,221,081
2,504,611
2,635,011
2,728,196
2,828,500
2,828,5002,728,1962,635,0112,504,6112,221,0811,978,6191,677,2571,648,3261,500,3461,367,4631,227,226924,4141,164,674534,424371,670296,418233,532208,020205,261000
       Property Plant Equipment 
0
0
0
176,508
178,376
182,499
192,103
216,544
280,147
356,509
392,261
614,394
672,051
744,035
785,267
819,041
876,835
893,853
1,043,300
1,038,476
1,034,085
1,070,437
1,070,4371,034,0851,038,4761,043,300893,853876,835819,041785,267744,035672,051614,394392,261356,509280,147216,544192,103182,499178,376176,508000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,089
7,057
7,662
7,662
7,662
7,662
7,6627,6627,6627,6627,0577,0890000000000000000
       Intangible Assets 
0
0
0
11,492
11,312
31,224
30,957
31,234
30,919
68,529
67,841
45,068
44,473
75,887
84,441
86,835
120,087
128,273
327,966
332,067
344,942
428,533
428,533344,942332,067327,966128,273120,08786,83584,44175,88744,47345,06867,84168,52930,91931,23430,95731,22411,31211,492000
> Total Liabilities 
0
0
0
84,989
278,684
710,488
718,443
708,949
863,587
637,720
704,883
819,623
900,184
864,770
1,660,989
1,152,811
994,795
878,681
1,029,298
1,216,441
1,167,851
1,218,127
1,218,1271,167,8511,216,4411,029,298878,681994,7951,152,8111,660,989864,770900,184819,623704,883637,720863,587708,949718,443710,488278,68484,989000
   > Total Current Liabilities 
0
0
0
73,363
266,045
697,526
696,729
688,689
810,775
593,028
651,211
760,710
834,489
797,945
1,571,726
1,087,835
912,977
771,774
919,153
720,856
671,039
714,280
714,280671,039720,856919,153771,774912,9771,087,8351,571,726797,945834,489760,710651,211593,028810,775688,689696,729697,526266,04573,363000
       Short-term Debt 
0
0
0
0
35,000
55,000
55,000
55,000
20,000
0
0
10,039
12,406
14,002
14,259
0
0
0
0
0
0
0
000000014,25914,00212,40610,0390020,00055,00055,00055,00035,0000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
10,039
12,406
14,002
14,259
12,378
9,743
9,557
9,000
9,000
9,000
9,000
9,0009,0009,0009,0009,5579,74312,37814,25914,00212,40610,03900000000000
       Accounts payable 
0
0
0
35,263
81,765
100,269
143,343
272,268
422,372
259,746
284,723
389,169
506,484
384,973
791,414
574,927
455,610
391,200
525,783
410,273
358,360
421,353
421,353358,360410,273525,783391,200455,610574,927791,414384,973506,484389,169284,723259,746422,372272,268143,343100,26981,76535,263000
       Other Current Liabilities 
0
0
0
33,442
110,248
333,895
374,535
249,356
256,459
238,130
248,459
361,503
315,598
398,969
766,053
992
744
652
796
609
477
509
509477609796652744992766,053398,969315,598361,503248,459238,130256,459249,356374,535333,895110,24833,442000
   > Long-term Liabilities 
0
0
0
11,626
12,638
12,961
21,714
20,260
52,812
44,693
53,672
58,913
65,695
66,825
89,264
64,977
81,819
106,907
110,145
495,584
496,812
503,847
503,847496,812495,584110,145106,90781,81964,97789,26466,82565,69558,91353,67244,69352,81220,26021,71412,96112,63811,626000
> Total Stockholder Equity
0
0
0
557,476
750,571
1,789,284
4,439,548
4,745,425
5,367,539
5,721,454
6,364,625
6,979,268
7,232,450
7,720,800
7,500,617
7,562,111
7,232,942
7,414,742
7,201,271
7,309,254
7,337,974
7,238,108
7,238,1087,337,9747,309,2547,201,2717,414,7427,232,9427,562,1117,500,6177,720,8007,232,4506,979,2686,364,6255,721,4545,367,5394,745,4254,439,5481,789,284750,571557,476000
   Common Stock
0
0
0
360,000
360,000
360,000
400,000
400,000
400,000
400,000
400,000
400,000
588,460
588,460
588,460
0
0
0
0
0
0
0
0000000588,460588,460588,460400,000400,000400,000400,000400,000400,000360,000360,000360,000000
   Retained Earnings Total Equity0000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
0
0
0
225,711
225,730
225,730
2,054,967
2,318,791
2,318,801
2,323,929
2,330,854
2,107,385
1,846,274
1,861,186
1,835,076
0
0
0
0
0
0
0
00000001,835,0761,861,1861,846,2742,107,3852,330,8542,323,9292,318,8012,318,7912,054,967225,730225,730225,711000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,007,119
Cost of Revenue-286,641
Gross Profit720,478720,478
 
Operating Income (+$)
Gross Profit720,478
Operating Expense-955,502
Operating Income51,617-235,024
 
Operating Expense (+$)
Research Development196,276
Selling General Administrative206,312
Selling And Marketing Expenses0
Operating Expense955,502402,588
 
Net Interest Income (+$)
Interest Income54,673
Interest Expense-2,409
Other Finance Cost-3,123
Net Interest Income49,141
 
Pretax Income (+$)
Operating Income51,617
Net Interest Income49,141
Other Non-Operating Income Expenses0
Income Before Tax (EBT)410,47851,617
EBIT - interestExpense = -2,409
363,721
366,130
Interest Expense2,409
Earnings Before Interest and Taxes (EBIT)0412,887
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax410,478
Tax Provision-62,311
Net Income From Continuing Ops348,167348,167
Net Income363,721
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-49,141
 

Technical Analysis of Sansure
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sansure. The general trend of Sansure is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sansure's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sansure Biotech Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 24.16 < 24.18 < 25.50.

The bearish price targets are: 19.52 > 19.39 > 18.46.

Tweet this
Sansure Biotech Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sansure Biotech Inc. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sansure Biotech Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sansure Biotech Inc. The current macd is 0.12334616.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sansure price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Sansure. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Sansure price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Sansure Biotech Inc Daily Moving Average Convergence/Divergence (MACD) ChartSansure Biotech Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sansure Biotech Inc. The current adx is 20.74.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Sansure shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Sansure Biotech Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sansure Biotech Inc. The current sar is 23.47.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Sansure Biotech Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sansure Biotech Inc. The current rsi is 45.65. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Sansure Biotech Inc Daily Relative Strength Index (RSI) ChartSansure Biotech Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sansure Biotech Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sansure price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Sansure Biotech Inc Daily Stochastic Oscillator ChartSansure Biotech Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sansure Biotech Inc. The current cci is -45.21334593.

Sansure Biotech Inc Daily Commodity Channel Index (CCI) ChartSansure Biotech Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sansure Biotech Inc. The current cmo is -17.91926717.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Sansure Biotech Inc Daily Chande Momentum Oscillator (CMO) ChartSansure Biotech Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sansure Biotech Inc. The current willr is -96.28378378.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Sansure Biotech Inc Daily Williams %R ChartSansure Biotech Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sansure Biotech Inc.

Sansure Biotech Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sansure Biotech Inc. The current atr is 0.81341966.

Sansure Biotech Inc Daily Average True Range (ATR) ChartSansure Biotech Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sansure Biotech Inc. The current obv is 101,605,473.

Sansure Biotech Inc Daily On-Balance Volume (OBV) ChartSansure Biotech Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sansure Biotech Inc. The current mfi is 64.30.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Sansure Biotech Inc Daily Money Flow Index (MFI) ChartSansure Biotech Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sansure Biotech Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-10BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-01-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-13MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Sansure Biotech Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sansure Biotech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.651
Ma 20Greater thanMa 5021.874
Ma 50Greater thanMa 10021.601
Ma 100Greater thanMa 20022.071
OpenGreater thanClose21.350
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Sansure with someone you think should read this too:
  • Are you bullish or bearish on Sansure? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sansure? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sansure Biotech Inc

I send you an email if I find something interesting about Sansure Biotech Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Sansure Biotech Inc.

Receive notifications about Sansure Biotech Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.